CN Patent

CN110590839B — 一种乐伐替尼衍生物及制备方法和用途

Assigned to Sichuan Haisco Pharmaceutical Co Ltd · Expires 2022-04-05 · 4y expired

What this patent protects

本发明涉及一种通式(I)所示化合物及其立体异构体或药学上可接受的盐，以及在制备用于抗肿瘤的药物中的应用，通式(I)化合物的结构为Q‑L‑R 1 ，其基团定义与说明书定义一致。

USPTO Abstract

本发明涉及一种通式(I)所示化合物及其立体异构体或药学上可接受的盐，以及在制备用于抗肿瘤的药物中的应用，通式(I)化合物的结构为Q‑L‑R 1 ，其基团定义与说明书定义一致。

Drugs covered by this patent

Patent Metadata

Patent number
CN110590839B
Jurisdiction
CN
Classification
—
Expires
2022-04-05
Drug substance claim
No
Drug product claim
No
Assignee
Sichuan Haisco Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.